Abstract
Purpose
In order to obtain dermal vehicles of ketorolac tromethamine (KT) for the local treatment of inflammation and restrict undesirable side effects of systemic levels hydrogels (HGs) of poloxamer and carbomer were developed.
Methods
KT poloxamer based HG (KT-P407-HG) and KT carbomer based HG (KT-C940-HG) were elaborated and characterized in terms of swelling, degradation, porosity, rheology, stability, in vitro release, ex vivo permeation and distribution skin layers. Finally, in vivo anti-inflammatory efficacy and skin tolerance were also assessed.
Results
HGs were transparent and kept stable after 3 months exhibiting biocompatible near neutral pH values. Rheological patterns fitted to Herschel-Bulkley for KT-C940-HG and Newton for KT-P407-HG due to its low viscosity at 25°C. Rapid release profiles were observed through first order kinetics. Following the surface the highest concentration of KT from C940-HG was found in the epidermis and the stratum corneum for P407-HG. Relevant anti-inflammatory efficacy of KT-P407-HG revealed enough ability to provide sufficient bioavailability KT to reach easily the site of action. The application of developed formulations in volunteers did not induce any visual skin irritation.
Conclusions
KT-P407-HG was proposed as suitable formulation for anti-inflammatory local treatment without theoretical systemic side effect.
Similar content being viewed by others
Abbreviations
- C940:
-
Carbopol® 940
- HG:
-
Hydrogel
- HPLC:
-
High performance liquid chromatography
- KT:
-
Ketorolac tromethamine
- P:
-
Porosity
- P407:
-
Pluronic® F-127
- PBS:
-
Phosphate buffer solution
- PEO:
-
Poly(ethylene oxide)
- PPO:
-
Poly(propylene oxide)
- SC:
-
Stratum corneum
- SCH:
-
Stratum corneum hydration
- SR:
-
Swelling ratio
- TEWL:
-
Trans epidermal water loss
- TPA:
-
12-O-detradecanoylphorbol-13-acetate
- WL:
-
Weight loss
References
De Oliveira Jr GS, Agarwal D, Benzon HT. Perioperative single dose ketorolac to prevent postoperative pain: ameta-analysis of randomized trials. Anesth Analg. 2012;114(2):424–33.
El-Setouhy DA, El-Ashmony SM. Ketorolac trometamol topical formulations: release behaviour, physical characterization, skin permeation, efficacy and gastric safety. J Pharm Pharmacol. 2010;62(1):25–34.
Ting WW, Vest CD, Sontheimer RD. Review of traditional and novel modalities that enhance the permeability of local therapeutics across the stratum corneum. Int J Dermatol. 2004;43(7):538–47.
Vega E, Egea MA, Garduño-Ramírez ML, García ML, Sánchez E, Espina M, Calpena AC. Flurbiprofen PLGA-PEG nanospheres: role of hydroxy-β-cyclodextrin on ex vivo human skin permeation and in vivo topical anti-inflammatory efficacy. Colloids Surf B: Biointerfaces. 2013;110:339–46.
Koop HS, de Freitas RA, de Souza MM, Savi-Jr R, Silveira JL. Topical curcumin-loaded hydrogels obtained using galactomannan from Schizolobium Parahybae and xanthan. Carbohydr Polym. 2015;116:229–36.
Guvendiren M, Lu HD, Burdick JA. Shear-thinning hydrogels for biomedical applications. Soft Matter. 2012;8:260e272.
Ahmed EM. Hydrogel: preparation, characterization, and applications: a review. J Adv Res. 2015;6(2):105–21.
Hoare TR, Kohane DS. Hydrogels in drug delivery: progress and challenges. Polymer. 2008;49:1993–2007.
Miguel SP, Ribeiro MP, Brancal H, Coutinho P, Correia IJ. Thermoresponsive chitosan-agarose hydrogel for skin regeneration. Carbohydr Polym. 2014;111:366–73.
de Araújo DR, da Silva DC, Barbosa RM, Franz-Montan M, Cereda CM, Padula C, et al. Strategies for delivering local anesthetics to the skin: focus on liposomes, solid lipid nanoparticles, hydrogels and patches. Expert Opin Drug Deliv. 2013;10(11):1551–63.
Brugués AP, Naveros BC, Calpena Campmany AC, Pastor PH, Saladrigas RF, Lizandra CR. Developing cutaneous applications of paromomycin entrapped in stimuli-sensitive block copolymer nanogel dispersions. Nanomedicine (London). 2015;10(2):227–40.
Chawla V, Saraf SA. Rheological studies on solid lipid nanoparticle based carbopol gels of aceclofenac. Colloids Surf B: Biointerfaces. 2012;92:293–8.
Das B, Nayak AK, Nanda U. Topical gels of lidocaine HCl using cashew gum and Carbopol 940: preparation and in vitro skin permeation. Int J Biol Macromol. 2013;62:514–7.
ICH harmonised tripartite guideline. Validation of analytical procedures: text and methodology Q2(R1). Geneva: ICH; 2005.
Guidance document for the conduct of skin absorption studies. OECD series on testing and assessment No.28. Paris: OECD; 2004.
Skin absorption: in vitro Method. OECD guideline for the testing of chemicals. Guideline 428.Paris: OECD; 2004.
Basic criteria for the in vitro assessment of dermal absorption of cosmetic ingredients. SCCS/1358. Brussels: Scientific Committee on Consumer Safety; 2010.
Williams AC. Transdermal and topical drug delivery. London: Pharmaceutical Press; 2003.
Flo A, Calpena AC, Halbaut L, Araya EI, Fernández F, Clares B. Melatonin delivery: transdermal and transbuccal evaluation in different vehicles. Pharm Res. 2016;33(7):1615–27.
Alonso C, Lucas R, Barba C, Marti M, Rubio L, Comelles F, et al. Skin delivery of antioxidant surfactants based on gallic acid and hydroxytyrosol. J Pharm Pharmacol. 2015;67(7):900–8.
Domínguez-Villegas V, Clares-Naveros B, García-López ML, Calpena-Campmany AC, Bustos-Zagal P, Garduño-Ramírez ML. Development and characterization of two nano-structured systems for topical application of flavanones isolated from Eysenhardtia Platycarpa. Colloids Surf B: Biointerfaces. 2014;116:183–92.
World medical association. World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–4.
Clarys P, Clijsen R, Taeymans J, Barel AO. Hydration measurements of the stratum corneum: comparison between the capacitance method (digital version of the Corneometer CM 825(R)) and the impedance method (Skicon-200EX(R)). Skin Res Technol. 2012;18(3):316–23.
Lee SG, Kim SR, Cho HI, Kang MH, Yeom DW, Lee SH, Lee S, Choi YW. Hydrogel-based ultra-moisturizing cream formulation for skin hydration and enhanced dermal drug delivery. Biol Pharm Bull. 2014;37(10):1674–82.
Cordero JA, Alarcon L, Escribano E, Obach R, Domenech J. A comparative study of the transdermal penetration of a series of nonsteroidal antiinflammatory drugs. J Pharm Sci. 1997;86(4):503–8.
Escobar-Chávez JJ, López-Cervantes M, Naïk A, Kalia YN, Quintanar-Guerrero D, Ganem-Quintanar A. Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations. J Pharm Pharm Sci. 2006;9(3):339–58.
Sierra AF, Ramirez ML, Campmany AC, Martinez AR, Naveros BC. In vivo and in vitro evaluation of the use of a newly developed melatonin loaded emulsion combined with UV filters as a protective agent against skin irradiation. J Dermatol Sci. 2013;69(3):202–14.
Tang C, Yin L, Pei Y, Zhang M, Wu L. New superporous hydrogels composites based on aqueous carbopol® solution (SPHCcs): synthesis, characterization and in vitro bioadhesive force studies. Eur Polym J. 2005;4(3):557–62.
Dong L, Liu C, Cun D, Fang L. The effect of rheological behavior and microstructure of the emulgels on the release and permeation profiles of Terpinen-4-ol. Eur J Pharm Sci. 2015;78:140–50.
Dewan M, Bhowmick B, Sarkar G, Rana D, Bain MK, Bhowmik M, et al. Effect of methyl cellulose on gelation behavior and drug release from poloxamer based ophthalmic formulations. Int J Biol Macromol. 2015;72:706–10.
Dumortier G, Grossiord JL, Agnely F, Chaumeil JC. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res. 2006;23(12):2709–28.
Almeida H, Amaral MH, Lobão P, Lobo JM. Pluronic F-127 and pluronic lecithin organogel (PLO): main features and their applications in topical and transdermal administration of drugs. J Pharm Pharm Sci. 2012;15(4):592–605.
Cevc G, Blume G. Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers. Transfersomes Biochim Biophys Acta. 2003;1614(2):156–64.
Mohammed D, Hirata K, Hadgraft J, Lane ME. Influence of skin penetration enhancers on skin barrier function and skin protease activity. Eur J Pharm Sci. 2014;51:118–22.
del Pozo A, Viscasillas A. Efficacy evaluation. In: Salvador A, Chisvert A, editors. Analysis of cosmetic products. Amsterdam: Elsevier; 2007. p. 462–74.
Shin SC, Cho CW, Oh IJ. Effects of non-ionic surfactants as permeation enhancers towards piroxicam from the poloxamer gel through rat skins. Int J Pharm 2001;222(2):199–203.
Erukova VY, Krylova OO, Antonenko YN, Melik-Nubarov NS. Effect of ethylene oxide and propylene oxide block copolymers on the permeability of bilayer lipid membranes to small solutes including doxorubicin. Biochim Biophys Acta. 2000;1468(1–2):73–86.
Demina T, Grozdova I, Krylova O, Zhirnov A, Istratov V, Frey H, et al. Relationship between the structure of amphiphilic copolymers and their ability to disturb lipid bilayers. Biochemistry. 2005;44(10):4042–54.
Acknowledgments and Disclosures
This work was supported by the Ministry of Science and Innovation of Spain for the financial (MAT2014-59134R). Prof. Juan Blasi and Inmaculada Gómez de Aranda from the Department of Pathology and Experimental Therapeutics are also acknowledged for their excellent technical support in histological studies. The authors report no conflict of interests, financial or otherwise. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
ESM 1
(PDF 91 kb)
Rights and permissions
About this article
Cite this article
Mallandrich, M., Fernández-Campos, F., Clares, B. et al. Developing Transdermal Applications of Ketorolac Tromethamine Entrapped in Stimuli Sensitive Block Copolymer Hydrogels. Pharm Res 34, 1728–1740 (2017). https://doi.org/10.1007/s11095-017-2181-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-017-2181-8